ASHP thinks Mevacor should not go OTC
ASHP believes Mevacor is not safe to go over the counter but might be appropriate for behind the counter.
Democrats urge FDA to test lipstick for lead
Sens. John Kerry, Diane Feinstein, and Barbara Boxer urge the FDA to test lipstick for lead
Study says: Consumers accept behind-the-counter drugs
Study finds consumers approve of behind-the-counter drugs
FDA's comment period for proposed sunscreen rule extended
FDA extends comment period for proposed sunscreen rule
New product automates IV dosing workflow
Software manages and tracks every IV dose administered by hospitals
Encore Tablets recalled by FDA, Bodee LLC
FDA, Bodee LLC issue nationwide recall of Encore Tablets
New products: November 19, 2007
New products include brand-name drugs, generics, home-health products, over-the-counter, and health and beauty care.
A pharmacist with dog in tow are Alzheimer's patients best friends
Peggy Memoli is recognized for her work with Alzheimer's patients. She is one of three recipients of 2007 Eisai award recognizing the role of pharmacists in Alzheimer's care.
Latebreakers: FDA gives nod to OTC Zyrtec-D for allergies
This drug combines an antihistamine with a nasal decongestant.
More novelty OTCs elbow onto store shelves
Manufacturers are launching new over-the-counter medicines that are innovative.
Cough and cold recommendations may impact other products
Two Food and Drug Administration advisory committees voted 13 to 9 to recommend that cough and cold over-the-counter medications not be used for children who are more than two and less than six years old.
Sparks fly at FDA hearing on behind-the-counter class of drugs
At an FDA public meeting to consider whether a behind-the-counter class of drugs should be set up, the agency heard from both supporters and detractors.
Public health group opposes feminine hygiene douching practices
APHA adopts policy against feminine hygiene douching practices
FDA asks for recall of dietary supplements for men
FDA requests recall of True Man Sexual Energy, Energy Max dietary supplements.
Dietary supplement adverse event reporting rules effective Dec. 22
Adverse event reporting rules for dietary supplements effective Dec. 22.
FDA, NIH, CHPA to hold adolescent OTC drug use workshop
FDA announces public workshop on OTC drug use among adolescents.
FDA forms Risk Communication Advisory Committee
FDA names 15 members for its new Risk Communication Advisory Committee.
Eight pharmacies to distribute pulmonary hypertension drug
Eight pharmacies chosen as Letairis distributors
More than $300,000 worth of drugs, supplements seized by marshals
U.S. Marshals seize more than $300,000 worth of drugs and dietary supplements
NACDS supports Dextromethorphan Abuse Reduction Act of 2007
NACDS applauds Dextromethorphan Abuse Reduction Act of 2007
Home hygiene helps tame MRSA
Home hygience can help tame MRSA, according to health care providers.
New Products, November 5, 2007
New drugs, generics, dosages and indications
Latebreakers: No cough, cold OTCs for kids two to under six
FDA advisory panel says OTC cough and cold meds should not be used by children under six.
Wyeth recalls some cough, cold drugs because of dosage cup
Wyeth recalls certain Robitussin, Dimetapp Cold & Chest Congestion.
FDA to hold meeting on OTC oral nasal decongestant ingredients
FDA meeting on ingredients in OTC oral nasal decongestants.
NextWave, Kerr Drug team up to offer MyKidz Iron
NextWave Pharmaceuticals and Kerr Drug to provide MyKidz Iron
FDA meeting to evaluate Mevacor going OTC
FDA to hold joint meeting to evaluate Merck's OTC use of Mevacor to help lower cholesterol and prevent heart attack.
Latebreakers: Associations have mixed reactions to behind-the-counter drugs
FDA's behind-the-counter drugs proposal draws mixed reactions from pharmacy associations
New Products October 22, 2007
Branded pharmaceuticals, generics, OTCs, home-health products, health and beauty items
